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DOI 10.1186/s13071-015-1098-5RESEARCH Open AccessAscaris lumbricoides β carbonic anhydrase: a
potential target enzyme for treatment of ascariasis
Reza Zolfaghari Emameh1,2,3*, Marianne Kuuslahti1, Daniela Vullo4,5, Harlan R. Barker1, Claudiu T. Supuran4,5
and Seppo Parkkila1,3Abstract
Background: A parasitic roundworm, Ascaris lumbricoides, is the causative agent of ascariasis, with approximately
760 million cases around the world. Helminthic infections occur with a high prevalence mostly in tropical and
developing xcountries. Therefore, design of affordable broad-spectrum anti-helminthic agents against a variety of
pathogens, including not only A. lumbricoides but also hookworms and whipworms, is desirable. Beta carbonic
anhydrases (β-CAs) are considered promising targets of novel anthelminthics because these enzymes are present in
various parasites, while completely absent in vertebrates.
Methods: In this study, we identified an A. lumbricoides β-CA (AIBCA) protein from protein sequence data using
bioinformatics tools. We used computational biology resources and methods (including InterPro, CATH/Gene3D,
KEGG, and METACYC) to analyze AlBCA and define potential roles of this enzyme in biological pathways. The AlBCA
gene was cloned into pFastBac1, and recombinant AIBCA was produced in sf-9 insect cells. Kinetics of AlBCA were
analyzed by a stopped-flow method.
Results: Multiple sequence alignment revealed that AIBCA contains the two sequence motifs, CXDXR and HXXC,
typical for β-CAs. Recombinant AIBCA showed significant CA catalytic activity with kcat of 6.0 × 105 s−1 and kcat/KM
of 4.3 × 107 M−1 s−1. The classical CA inhibitor, acetazolamide, showed an inhibition constant of 84.1 nM. Computational
modeling suggests that the molecular architecture of AIBCA is highly similar to several other known β-CA structures.
Functional predictions suggest that AIBCA might play a role in bicarbonate-mediated metabolic pathways, such as
gluconeogenesis and removal of metabolically produced cyanate.
Conclusions: These results open new avenues to further investigate the precise functions of β-CAs in parasites and
suggest that novel β-CA specific inhibitors should be developed and tested against helminthic diseases.
Keywords: Ascaris lumbricoides, Beta carbonic anhydrase, Enzyme inhibition, Sulfonamide, Acetazolamide, Bioinformatics,
Computational biology, AscariasisBackground
Two parasitic worms, Ascaris lumbricoides and Ascaris
suum were independently nominated by Linnaeus in
1758 and Goeze in 1782, respectively. Recent genetic
and paleoparasitological evidence has suggested that
these strains are, in fact, a single species [1]. Therefore,
the original name, A. lumbricoides, should be used upon
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stated.Around 760 million people worldwide are infected
with A. lumbricoides, mainly in Southeast Asia [2]. The
human ascariasis infection is normally caused by feces
contamination in water, vegetables, and other food. The
eggs of the worm hatch into larvae within the small
intestine. The larvae spread through the blood stream to
different organs and finally arrive in the lung. From the
lungs they eventually enter the throat and are swallowed.
In the intestinal tract, the larvae complete development
into adult worms. A female A. lumbricoides worm can
produce 240,000 eggs daily, which pass within feces to
the environment to begin the cycle anew. The eggs are
resistant to cold weather and disinfectants and cans This article is distributed under the terms of the Creative Commons
ativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution,
u give appropriate credit to the original author(s) and the source, provide a link
e if changes were made. The Creative Commons Public Domain Dedication
ain/zero/1.0/) applies to the data made available in this article, unless otherwise
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high load of nematodes in ascariasis, there are also
severe complications including intestinal obstruction,
peritonitis, and acute pancreatitis [3]. There are different
treatment strategies for ascariasis, such as surgery (in case
of bowel obstruction) and application of anthelminthic
drugs including albendazole, mebendazole, and pyrantel
pamoate. At present and in the future, access to new
broad-spectrum anthelmintics against A. lumbricoides,
as well as hookworms and whipworms, are needed in
countries where these infections are endemic [4].
Carbonic anhydrases (CAs) have been recently identified
as potential targets for novel anti-infective drugs. CAs are
encoded by six evolutionary divergent gene families:
α, β, γ, δ, ζ, and η CAs [5–7]. All members of these
gene families are metalloenzymes, which usually contain
zinc ion in their catalytic active site [8]. Certain ζ- and
γ-CAs contain cadmium (II), iron (II) or cobalt (II) as
alternative metal ion cofactors [9–11]. α-CAs are the
most intensively studied family, which contains 13 cata-
lytically active members in mammals: cytosolic enzymes
(CA I, CA II, CA III, CA VII, and CA XIII), membrane-
bound (CA IV, CA IX, CA XII, CA XIV, and CA XV),
mitochondrial CAs (VA and CA VB), and secreted CA
(VI) [12]. β-CAs are found in plants, algae, fungi, bacteria,
protozoans, arthropods, and nematodes [6, 13, 14]; γ-CAs
in algae, plants, bacteria, and archaea [15]; δ-CAs in free-
living marine dinoflagellates [16]; ζ-CAs in marine dia-
toms [9]; and η-CAs in Plasmodium parasites [5]. CAs
play a critical role in many biochemical pathways, includ-
ing respiration, pH homeostasis, electrolyte transfer, bone
resorption, calcification, gluconeogenesis, lipogenesis, and
ureagenesis [12, 17]. Because β-CA genes are absent in
vertebrate genomes, while present in many parasite
genomes, they are considered potential candidate tar-
get enzymes for novel anti-infectives [6, 7, 18, 19].
Literature on CA inhibition reveals that many inhibi-
tors, such as sulfonamide, sulfamides, sulfamates, an-
ions, phenols, coumarins, dithiocarbamates, fullerenes,
boronic acids, carboxylates, polyamines, benzamides,
hydroxymates, and mercaptans have been tested against
β-CAs to control infectious organisms, such as Can-
dida albicans, Cryptococcus neoformans, Leishmania
donovani, Salmonella typhimurium, Porphyromonas
gingivalis, Helicobacter pylori, Streptococcus pneumo-
niae, Mycobacterium tuberculosis, and Brucella suis
[20–27]. Meanwhile, inhibitory studies have been also
carried out on β-CAs from non-pathogenic model or-
ganisms, including Saccharomyces cerevisiae and Dros-
ophila melanogaster [12, 28–34].
In this study, we analyzed properties of A. lumbri-
coides β-CA (AlBCA) using bioinformatics tools, pro-
duced AlBCA as a recombinant protein in insect cells,
and tested its kinetic and inhibition properties. Theseinvestigations represent the first experimental study on a
β-CA protein from a parasitic nematode.
Methods
Identification of AlBCA protein sequence
A β-CA protein sequence from Caenorhabditis elegans
(Uniprot ID: Q2YS41) [35] was used for the initial NCBI
BLAST protein homology search (http://blast.ncbi.nlm.
nih.gov/Blast.cgi). Ten nematode β-CA protein sequences,
including AlBCA, were aligned with the Clustal Omega
algorithm to create a multiple sequence alignment (MSA)
within the Jalview program (version 2.8.ob1) (http://
www.jalview.org/).
Structural and functional predictions based on AlBCA
sequence
The AlBCA protein sequence (Uniprot ID: F1LE18) was
used as a query in the integrative protein signature data-
base, InterPro (http://www.ebi.ac.uk/interpro/). This data-
base integrates together predictive models of representative
protein domains, families, and functional sites from mul-
tiple and diverse databases, such as Gene3D, PANTHER,
Pfam, PIRSF, PRINTS, ProDom, PROSITE, SMART,
SUPERFAMILY, and TIGRFAMs [36]. The resulting
InterPro ID (IPR001765) for AlBCA protein sequence
was used as a query in the CATH/Gene3D database
(http://www.cathdb.info/) [37]. This database hierarch-
ically classifies domains into sequence and structure-
based families and fold groups, when there is a sufficient
evidence for having diverged from a common ancestor.
The CATH/Gene3D database generated a rainbow model
for superimposed AlBCA protein sequence and several
other close species. We also identified the biochemical
pathways and interactions of AlBCA through KEGG
(Kyoto Encyclopedia of Genes and Genomes) (http://
www.kegg.jp/) [38] and METACYC metabolic pathway
databases (http://metacyc.org/) [39], which have both been
linked to InterPro.
Production of recombinant AlBCA
The CDS sequence of AlBCA gene was retrieved from
the EMBL database (http://www.ebi.ac.uk/). GeneArt®
gene synthesis technology (Life Technologies) was used
to construct the β-CA gene sequence for insertion into
the cloning vector (pFastBac1) [40]. DH10Bac cells
(which contain the bacmid baculovirus shuttle vector,
and a helper plasmid that produces the proteins needed
for transposition), were transformed by pFast-AlBCA [7].
Then pFast-AlBCA was purified by PureLink™ HiPure
Plasmid Purification Kit (Invitrogen).
Primary transfection of Spodoptera frugiperda (sf-9)
insect cells for production of Baculoviruses was per-
formed by HilyMax transfection reagent (Dojindo)
(0.5×107 cells/ml in 6-well plates), and the cells were
Table 1 IDs for ten β-CA protein sequences from nematodes
Nematode name β-CA protein IDsa
Ascaris lumbricoides F1LE18
Caenorhabditis brenneri G0MRG1
Caenorhabditis briggsae A8WN21
Caenorhabditis elegans Q22460 (bca-1)
Q2YS41 (bca-2, isoform c)
D3NQA9 (bca-2, isoform d)
Caenorhabditis remanei E3MK96
Haemonchus contortus U6PDI1
Necator americanus W2SJ13
Saccoglossus kowalevskii NP_001171747.1b
Strongyloides ratti A0A090LV46
Toxocara canis KHN75516.1
aUniprot β-CA protein IDs
bNCBI β-CA protein ID
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fuged, passed through a 0.2 μm filter, and stored in a
dark tube at +4 °C. For secondary transfection, 20 ml of
cultured cells (2×106/ml) were transfected with a pri-
mary stock of Baculoviruses and incubated for 3 days in
a 29 °C shaker. Cultured cells were centrifuged, passed
through 0.2 μm filter, and stored in a dark tube at +4 °C.
For the expression of recombinant AlBCA, the second-
ary stocks of Baculoviruses were used to infect sf-9 cells
(2×106/ml) (using the same procedure as described for
the production of the secondary stock, but at higher
volumes).
The sf-9 cell culture medium was centrifuged at 5000
RPM for 10 min at room temperature. The supernatant
containing secreted AlBCA was diluted at a ratio of 1:5
by binding buffer (0.1 M Tris, 0.2 M Na2SO4, pH 8).
Then Protino™ Ni-NTA Agarose (Macherey-Nagel) was
added to the diluted culture medium and put on a mag-
netic stirrer with a low rotation speed (2 h at room
temperature and overnight incubation at +4 °C without
stirring). The culture medium was poured into the fun-
nel filtration system and passed through Whatman® filter
paper by vacuum. The flow-through was collected in a
separate vial. The agarose was washed with the wash
buffer (50 mM Na2HPO4, 0.5 M NaCl, 20 mM Imidazol,
pH 8). Elution buffer (50 mM Na2HPO4, 0.5 M NaCl,
0.25 M Imidazol, pH 8) was added into the column to
finally elute the recombinant AlBCA. Thrombin treat-
ment did not cleave the polyhistidine tag in spite of sev-
eral attempts (data not shown) probably due to the
specific molecular folding of AlBCA that completely hid
the thrombin cleaving site. Therefore, the kinetic mea-
surements were carried out using recombinant AlBCA
containing the polyhistidine tag.
Kinetic characterization of AlBCA
An Applied Photophysics stopped-flow instrument has
been used for assaying the CA catalyzed CO2 hydration
activity [41]. Phenol red (at a concentration of 0.2 mM)
has been used as indicator, working at the absorbance
maximum of 557 nm, with 20 mM TRIS (pH 8.3) as buf-
fer, and 20 mM NaClO4 (for maintaining a constant
ionic strength; this anion is not inhibitory against AlBCA
up to concentrations of 50 mM, data not shown), following
the initial rates of the CA-catalyzed CO2 hydration reac-
tion for a period of 10–100 s. The CO2 concentrations
ranged from 1.7 to 17 mM for the determination of the
kinetic parameters (by Lineweaver-Burk plots) and inhib-
ition constants. For each measurement at least six traces of
the initial 5-10 % of the reaction have been used for deter-
mining the initial velocity. The uncatalyzed rates were de-
termined in the same manner and subtracted from the
total observed rates. The inhibition constant of acetazol-
amide (AAZ, 5-acetamido-1,3,4-thiadiazole-2-sulfonamide)was obtained by non-linear least-squares methods using
PRISM 3 and the Cheng-Prusoff equation, as reported
earlier [42, 43], and represents the mean from at least
three different determinations.
Results
Identification of AlBCA protein sequence
Multiple sequence alignment (MSA) revealed that all 10
β-CA protein sequences from nematodes contained the
first (CXDXR; C: cysteine, D: aspartic acid, R: arginine,
X: any residue) and second (HXXC; H: histidine, C: cyst-
eine, X: any residue) highly conserved sequence motifs
of the catalytic site, which are the hallmark residues for
β-CAs (Table 1, Fig. 1). In addition, the neighbor resi-
dues present within or close to the active site were al-
most identical.
Structural and functional predictions based on AlBCA
sequence
Analysis of the AlBCA protein sequence by the InterPro
database resulted in classification as part of the carbonic
anhydrase family InterPro ID IPR001765. In the CATH/
Gene3D database, AlBCA is categorized with the CATH
superfamily ID 3.40.1050.10 (Beta-carbonic Anhydrase;
Chain A). The tools of CATH/Gene3D database were
used to generate a rainbow model for superimposition of
AlBCA protein with other close relative β-CA proteins
(Fig. 2). Metabolic pathway analyses of the AlBCA pro-
tein sequence in the KEGG and METACYC databases
predict that the enzyme plays a major role in nitrogen
metabolism (Fig. 3) and gluconeogenesis ll pathways
(Figs. 4 and 5). Results from the KEGG database sug-
gested that AlBCA might functionally participate in de-
toxification of cyanate by providing bicarbonate for
cyanase enzyme. The METACYC database also predicted
Fig. 1 Multiple sequence alignment (MSA) of β-CA protein sequences from 10 nematodes. Only the central region of the sequences (85 amino
acids, starting 3 amino acids prior to first highly conserved motif) are shown in this alignment. MSA revealed that all of them including AlBCA
contain the first (CXDXR; C: cysteine, D: aspartic acid, R: arginine, X: any residue) and second (HXXC; H: histidine, C: cysteine, X: any residue) highly
conserved sequences, which have been indicated by two black arrows at the bottom. Zinc ion (Zn2+) is the metal cofactor in catalytic active site
of β-CAs, which binds to Cys from the first motif and His and Cys from the second motif [55]
Zolfaghari Emameh et al. Parasites & Vectors  (2015) 8:479 Page 4 of 10bicarbonate as the final product of the β-CA catalytic
reaction. This bicarbonate would be needed for the
mitochondrial gluconeogenic pathway where pyruvate
is converted to oxaloacetate.
Production and characterization of recombinant AlBCA
A β-CA gene insert, including a thrombin cleavage site
and a segment encoding a poly-histidine tag, was pro-
duced by GeneArt® technology and integrated into aFig. 2 A rainbow model for superimposition of AIBCA and β-CAs of
close relative species. This image has been generated from a
superposition of nine representative domains within this superfamily.
The domain positions and protein structures appear to be highly similar
in this modelpFastBac1 plasmid (Additional file 1: Figure S1). The
purified plasmid was used to produce recombinant
AlBCA in sf-9 cells. SDS-PAGE containing the eluted
fraction showed three polypeptide bands of 28, 30, and
33 kDa. The 30-kDa band was the major product,
which corresponds to the calculated molecular mass of
AlBCA (Fig. 6).Kinetic properties of AlBCA
We have measured the kinetic properties of AlBCA for
the physiologic reaction of CO2 hydration to bicarbonate
and protons at pH 8.3 where, irrespective if this protein
is a type I or type II β-CA, the active site should be
open. The Zn (II) ion is coordinated by two Cys and one
His residues as well as by a water molecule/hydroxide
ion, acting as a nucleophile in the catalyzed reaction.
We compared the activity of the new enzyme with those of
well characterized α-class (human CA I and II) and β-CAs
from Leishmania donovani chagasi (LdcCA), Drosophila
melanogaster (DmBCA), and Anopheles gambiae (AgaCA),
characterized earlier by our group [7, 21, 44]. As displayed
in Table 2, AlBCA has significant catalytic activity in the
physiologic reaction with the following kinetic parameters:
kcat of 6.0 × 10
5 s−1 and kcat/Km of 4.3 × 10
7 M−1 s−1. The
measured kinetic parameters show that AlBCA has a mod-
erate activity, comparable to that of the relatively slower
human carbonic anhydrase isoform hCA I, and in the same
range as the enzymes characterized in Anopheles gambiae
and Leishamania donovani chagasi [7, 21]. Furthermore,
this activity has been effectively inhibited by the sulfona-
mide compound acetazolamide, which showed an inhib-
ition constant of 84.1 nM. Although this was the only
inhibitor investigated so far for this enzyme, work is in pro-
gress to understand in detail the inhibitory profiles of the
main classes of activity modulators against this enzyme,
Fig. 3 The predicted role of AlBCA in nitrogen metabolism pathway. This pathway has been generated by the KEGG (Kyoto Encyclopedia of
Genes and Genomes) database. According to this model AlBCA catalyzes the conversion of CO2 and H2O to HCO3
−. Cyanase converts cyanate to
CO and NH in a bicarbonate-dependent reaction
Fig. 4 Role of AlBCA in gluconeogenesis ll pathway. The conversion of CO2 to HCO3
− is catalyzed by β-CA, which is shown with a blue arrow.
Bicarbonate is then used for conversion of pyruvate to oxaloacetate
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Fig. 5 Role of bicarbonate generated by AIBCA in gluconeogenesis ll pathway. The conversion of CO2 to HCO3
− is catalyzed by β-CA, which is
shown with a purple arrow. HCO3
− is a major element in conversion of pyruvate to oxaloacetate. Oxaloacetate is used to generate aspartate,
citrate, and phosphoenolpyruvate through transamination, citric acid cycle, and gluconeogenesis pathways, respectively
Fig. 6 SDS-PAGE of AIBCA. Left lane shows the protein standard.
The purified recombinant AIBCA appeared as a triple band (28, 30,
and 33 kDa). The predicted molecular mass of His-tagged AlBCA
was 30 kDa
Zolfaghari Emameh et al. Parasites & Vectors  (2015) 8:479 Page 6 of 10i.e., anions, sulfonamides and their isosteres, and dithiocar-
bamates and their isosteres.
Discussion
Multiple sequence alignment (MSA) has confirmed the
presence of a β-CA enzyme in the proteome of A. lum-
bricoides, an important pathogen which is the causative
agent of the parasitic roundworm disease, ascariasis.
After this discovery our aim was focused on investiga-
tion of the putative functions of this enzyme by bioinfor-
matics prediction tools, production as a recombinant
protein, and characterization of its kinetic properties.
We determined that AlBCA protein contains the first
(CXDXR) and second (HXXC) hallmark sequences of β-
CAs, and most of the neighbor residues present within
or near the active site of the enzyme were also highly
homologous compared to other aligned nine helminthic
β-CAs. This result suggested that AlBCA is a catalytically
active enzyme. The rainbow model of AlBCA protein was
generated by superimposing its nine protein domains with
β-CA proteins from close species. α-helices and β-sheets
structures showed a high similarity in general domain
architecture. We successfully produced recombinant
AlBCA protein in Sf-9 insect cells. The SDS-PAGE ana-
lysis of the purified recombinant protein showed three
polypeptide bands with molecular masses of 28, 30, and
33 kDa. Among them the middle band was clearly stron-
gest and probably represents mature recombinant AlBCA
protein. The lower 28-kDa polypeptide band variably ap-
peared in SDS-PAGE analyses, and it probably represents
a partially degraded protein. The upper 33-kDa polypep-
tide might represent a premature form of the enzyme.
Even though our previous predictions for subcellular
localization did not provide any definitive result [6], the
Table 2 Kinetic parameters for the CO2 hydration reaction
catalysed by the human isozymes hCA I, II, III, IV, VA, VB, VI, VII,
IX, XII, XIII, and XIV (α-class CAs) and the β-CAs from Leishmania
donovani chagasi (LdcCA), Drosophila melanogaster (DmBCA),
Anopheles gambiae (AgaCA) and Ascaris lumbricoides (AlBCA)
Enzyme Class kcat (s−1) kcat/Km
(M−1x s−1)
Ki (acetazolamide)
(nM)a
hCA I α 2.0×105 5.0×107 250 ± 12
hCA II α 1.4×106 1.5×108 12 ± 0.8
hCA III α 1.3×104 2.5×105 240000 ± 25000
hCA IV α 1.1×106 5.1×107 74 ± 5.5
hCA VA α 2.9×105 2.9×107 63 ± 2.1
hCA VB α 9.5×105 9.8×107 54 ± 3.0
hCA VI α 3.4×105 4.9×107 11 ± 0.7
hCA VII α 9.5×105 8.3×107 2.5 ± 0.11
hCA IX α 1.1×106 1.5×108 16 ± 0.8
hCA XII α 4.2×105 3.5×107 5.7 ± 0.04
hCA XIII α 1.5×105 1.1×107 16 ± 0.3
hCA XIV α 3.1×105 3.9×107 41 ± 2.2
LdcCA β 9.35×105 5.9 ×107 91.7 ± 5.7
DmBCA β 9.5×105 1.1×108 516 ± 24
AgaCA β 7.2×105 5.6×107 27.3 ± 2.0
AlBCAa β (6.0 ± 0.1) ×105 (4.3 ± 0.2) ×107 84.1 ± 2.9
aMean ± standard error from three different assays
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secretory protein like the other parasite β-CAs defined so
far. Our previous studies have shown that there are exam-
ples of metazoan β-CAs in both subcellular locations [6].
Several species, such as Saccoglossus kowalevskii, Trichi-
nella spiralis, and Strigamia maritima, possess mitochon-
drial β-CAs. The highest score for a secretory signal
peptide was predicted to the β-CA of malaria mosquito
Anopheles darlingi. In our previous analysis using the
SignalP server, the β-CA of malaria mosquito Anopheles
darlingi had the highest score in likelihood to be a se-
creted protein [6]. In the functional predictions performed
by computational tools, AlBCA associated to conversion
of CO2 and H2O to bicarbonate, as expected. Then bicar-
bonate was functionally linked to detoxification of cyanate,
which is a toxic byproduct of some metabolites, such as
urea and carbamoylphosphate. Cyanase catalyzes the de-
composition of cyanate into CO2 and ammonia. Bicarbon-
ate serves as a nucleophilic reactant that attacks and
breaks down the cyanate, with carbamate as an unstable
intermediate. Therefore, the role of CA in recycling of
CO2 into bicarbonate, and the importance of bicarbonate
in the nitrogen metabolism pathway whole metabolic
process, are evident [45]. Furthermore, it was predicted
that β-CA plays a role in gluconeogenesis ll pathway. If
AlBCA locates in mitochondria, it would generate bicar-
bonate as the key element for conversion of pyruvate toother final products, such as aspartate, citrate, and phos-
phoenolpyruvate through transamination, citric acid cycle,
and gluconeogenesis, respectively. Indeed, our results have
indicated that AlBCA shows a significant catalytic activity
for the conversion of CO2 into bicarbonate, as demon-
strated in vitro by stopped-flow kinetic measurements.
Identification of β-CA from C. elegans in the Ensembl
Metazoa database (http://metazoa.ensembl.org/index.html)
[46] revealed that this model nematode contains three full-
length β-CA protein sequences (Additional file 2: Table S1).
An MSA of these β-CAs with AlBCA sequence, cre-
ated with the Clustal Omega algorithm (http://www.
ebi.ac.uk/Tools/msa/clustalo/) [47], showed that β-
CA2 (isoform c, Uniprot ID: Q2YS41) from C. elegans
is most similar to AlBCA. Thus, there is the possibil-
ity that the expression pattern of AlBCA is similar to C.
elegans β-CA2 (isoform c). The expression of C. elegans β-
CA2 (isoform c, Ensembl gene ID WBGene00013805) in
the WormViz expression database (http://www.vanderbilt.
edu/wormdoc/wormmap/WormViz.html) of WormBase
(https://www.wormbase.org/#01-23-6) [48] showed that β-
CA2 (isoform c) is expressed in all larval (EE, LE, L1, L2,
L3, L4) and adult (including male and hermaphrodites)
stages. The highest expression levels were detected in the
body wall muscles of L2 stage. The results defined that β-
CA is also present in larval neurons, muscles, coelomo-
cytes, hypodermis layer, intestine, and excretory cells. In
addition, β-CA2 (isoform c) is detectable in the whole
body of adult male and hermaphrodite gonads of C. ele-
gans. Previously, Fasseas et al. investigated the function of
C. elegans β-CA using an RNAi technique [35]. They did
not find any significant phenotypic change, which might
be due to several reasons. First, other CA isoforms might
compensate the lack of one β-CA. Second, the efficiency
of gene silencing might have been inadequate due to chal-
lenges with RNAi technique. In another model organism,
D. melanogaster, the highest upregulated values of β-CA
mRNA were observed in the spermatheca (female), fat
body, and heart of adults; as well as early larval stages and
late in metamorphosis [7]. The knockdown studies of D.
melanogaster β-CA showed a clear phenotypic change.
Surprisingly, females were sterile and unable to produce
eggs. An apparent defect was shown in migration of
border cells, which probably contributed to infertility of
female D. melanogaster [49].
For in vivo inhibitory studies, acetazolamide has been
tested on live C. elegans [50] and Plasmodium falcip-
arum (malaria parasite) [51]. These studies showed,
however, that acetazolamide could not penetrate
through the nematode cuticle or protozoan surface. A
BLAST search using 14 human α-CAs as queries re-
cently identified six α-CAs (CAH-1 to 6) in C. elegans
[52]. Güzel et al. [53] carried out an inhibition study on
C. elegans CAH-4 and 13 mammalian CAs using
Zolfaghari Emameh et al. Parasites & Vectors  (2015) 8:479 Page 8 of 10different sulfonamide derivatives including 2-(hydrazi-
nocarbonyl)-3-phenyl-1H-indole-5-sulfonamides of type 1
and 2, and compared their inhibition efficacy with trad-
itional CA inhibitors including acetazolamide (AZA) and
ethoxzolamide (EZA). Their study defined that some of
the new derivatives displayed excellent inhibitory action
on CAH-4 with Ki as low as 6 nM, which was 5.83 times
better value compared to AZA. Within this context,
AZA and EZA showed moderate inhibitory effects
on CAH-4. In another study, Giacomotto et al. [52]
realized that cah-4 null mutant C. elegans nematodes
were nonviable, and knockdown experiments, using
the RNAi technique, showed reduced muscle degen-
eration in dystrophin deficient muscle. Furthermore,
cah-4 RNAi treatment caused a significant shift in
the dose response curves of CA inhibitors, methazo-
lamide and dichlorphenamide. Giacomotto and co-
workers concluded that their studies confirmed the
suitability of C. elegans as a model organism for screening,
identifying and characterizing potential lead pharmaco-
logical agents [52].
Albendazole and Mebendazole are drugs quite well-
tolerated when used against ascariasis and resistance
has not yet been a major issue. Novel anthelmintic ap-
proaches are needed, however, because global health-
care will likely face these challenges at some point,
since millions of people require treatment [2, 54]. In-
hibition of AlBCA by single dose and broad-spectrum
inhibitors, which are effective against various helminthic
infections, would be a novel strategy for treatment of as-
cariasis. It could potentially disrupt the normal detoxifica-
tion of cyanate, which would in turn increase the
intracellular cyanate concentration to a toxic level, leading
to the death of the parasite.
Conclusions
β-CAs represent promising targets for novel anti-
parasitic drug design. In the future, new broad-
spectrum, and preferably single dose β-CA inhibitors,
should be designed against AlBCA and corresponding
enzymes of whipworms and hookworms. For the mo-
ment, the clinically used sulfonamide acetazolamide,
the only inhibitor tested so far, showed a promising
in vitro inhibitory power, with an inhibition constant of
84.1 nM on AlBCA. Acetazolamide’s inability to pene-
trate the nematode is an obvious problem. Therefore,
further studies should be planned to improve the pene-
tration efficacy of CA inhibitors through biological
membranes and cuticles of worms. The new sulfona-
mide derivatives, which were recently shown to in-
hibit C. elegans α-CAs, could represent useful leads
for design of novel compounds having higher effi-
ciency, better penetration, and minimal side effects on
human CAs.Additional files
Additional file 1: Figure S1. Construction of pFast-AlBCA cloning vector
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